Liposomal bupivacaine—a new tool in our armamentarium?
Almost two decades on from when Enhanced Recovery Programs (ERPs), consisting of multi-modal therapies to reduce surgical stress, were first proposed by Kehlet et al. the complexity of ERPs has increased, with interventions now utilized pre-, intra- and post-operatively (1). Whilst the use of ERPs has been demonstrated to significantly reduce patient morbidity and mortality, and reduce costs to the healthcare system, what constitutes the gold standard ERP has yet to be defined and significant variation in practice exists (2). Despite improvements in ERPs pain remains the primary cause of delayed discharge, as well as a common cause of re-admission, following orthopaedic surgery (3).